Legend Biotech (ADR) (LEGN)
Commercializes CARVYKTI while developing next-generation CAR-T therapies.
$18.51
After hours−0.13 (−0.70%)
At close$18.64(+0.59%)
Something off on this page? Send us feedback.
Next report
Nov 11, 26
in 50 days
EPS estimate
$0.02
Revenue estimate
$361.4M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.15−$0.07−$0.34−$0.11−$0.08−$0.15$0.09Pending
Estimate−$0.25−$0.23−$0.11−$0.13−$0.17−$0.02$0.12$0.02
Surprise+39.5%+69.0%−199.7%+15.4%+52.9%−650.0%−25.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$186.5M$195.1M$255.1M$272.3M$306.3M$305.1M$387.5MPending
Estimate$178.9M$193.6M$229.0M$274.4M$307.8M$306.5M$356.0M$361.4M
Surprise+4.3%+0.7%+11.4%−0.8%−0.5%−0.5%+8.9%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.82 | — | — |
| Sep 2028 | $0.32 | — | — |
| Jun 2028 | $0.26 | — | — |
| Mar 2028 | $0.23 | — | — |
| Dec 2027 | $0.27 | — | — |
| Sep 2027 | $0.25 | — | — |
| Jun 2027 | $0.20 | — | — |
| Mar 2027 | $0.19 | — | — |
| Dec 2026 | $0.03 | — | — |
| Nov 2026 | $0.02 | — | — |
| Aug 2026 | $0.12 | $0.09 | −25.0% |
| May 2026 | −$0.02 | −$0.15 | −650.0% |
| Mar 2026 | −$0.17 | −$0.08 | +52.9% |
| Nov 2025 | −$0.13 | −$0.11 | +15.4% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| Jun 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.82 | — | — | $566.7M | — | — | — |
| Sep 2028 | $0.32 | — | — | $566.7M | — | — | — |
| Jun 2028 | $0.26 | — | — | $494.4M | — | — | — |
| Mar 2028 | $0.23 | — | — | $470.9M | — | — | — |
| Dec 2027 | $0.27 | — | — | $527.1M | — | — | — |
| Sep 2027 | $0.25 | — | — | $473.6M | — | — | — |
| Jun 2027 | $0.20 | — | — | $440.7M | — | — | — |
| Mar 2027 | $0.19 | — | — | $422.8M | — | — | — |
| Dec 2026 | $0.03 | — | — | $386.9M | — | — | — |
| Nov 11, 2026 | $0.02 | — | — | $361.4M | — | — | — |
| Aug 11, 2026 | $0.12 | $0.09 | −25.0% | $356.0M | $387.5M | +8.9% | +5.7% |
| May 12, 2026 | −$0.02 | −$0.15 | −650.0% | $306.5M | $305.1M | −0.5% | +10.5% |
| Mar 10, 2026 | −$0.17 | −$0.08 | +52.9% | $307.8M | $306.3M | −0.5% | +2.2% |
| Nov 12, 2025 | −$0.13 | −$0.11 | +15.4% | $274.4M | $272.3M | −0.8% | −2.7% |
| Aug 11, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 11, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 9, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 11, 2024 | |||||||
| Nov 20, 2023 | |||||||
| Aug 15, 2023 | |||||||
| May 18, 2023 | |||||||
| Feb 17, 2023 | |||||||
| Sep 30, 2022 | |||||||
| Jun 1, 2022 | |||||||
| Mar 18, 2022 | |||||||
| Nov 16, 2021 | |||||||
| Aug 23, 2021 | |||||||
| May 18, 2021 | |||||||
| Mar 18, 2021 | |||||||
| Nov 16, 2020 | |||||||
| Aug 28, 2020 | |||||||
| Jun 8, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 |